Pharmatek Laboratories, a chemistry development organization, has opened its new 34,000-sq.-ft. facility in San Diego. The new location will initially more than triple Pharmatek’s available laboratory and manufacturing space and house more than 100 employees focused on analytical development, preformulation testing, formulation development, GMP manufacturing, and stability storage and testing. The facility strengthens Pharmatek’s drug development capabilities and its ability to continue the growth it has experienced during the past eight years. The company’s lease includes an option to expand to 64,000 sq. ft.

“The new facility will support our rapidly growing pharmaceutical development business with space for additional expansion in the future,” said Timothy Scott, president of Pharmatek. “The increased space enables us to enhance both our capacity and services. We can now conduct a larger number of projects and provide our clients with better service on those projects.”

“From the GMP viewing area to the layout and flow of the manufacturing, analytical and formulation labs, the entire facility was built with our clients’ needs in mind,” said Dr. Jeffrey Bibbs, chief executive officer and chief scientific officer of Pharmatek. “Our focus has always been on our clients. This larger facility, built to our specifications, will better meet their growing need for drug development outsourcing.”